Terry is a Partner and Head of Venture Growth Equity Investments. He invests in venture and growth-oriented companies with a focus on the healthcare space. Terry sits on the Boards of Directors of Aptinyx, Corvus, LifeBond, OncoMed (NADSAQ: OMED), Orbus Pharmaceuticals, and Outpost Medicine. He is a former board member at CombiChem, INC Research, Incline Therapeutics, and Proteus Digital Health. Terry is also a member of the Adams Street Executive and Direct Investment Committees.
Terry's past investments include:
Brinson Partners/UBS Global Asset Management
Trinity Ventures, Ltd.
Boston Consulting Group
Dartmouth College, BA
Stanford University, MBA